...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Broker Meeting 23 Feb
6
Feb 28, 2017 09:05PM
3
Feb 28, 2017 09:29PM
3
Mar 01, 2017 12:37PM

BDAZ - I posted what I had heard from the 3 sources so I can not comment on anything else. If someone has access to notes made at this meeting it would be great if they could post them.

tada

Share
New Message
Please login to post a reply